Präsentationen
Aktie
Aktueller Finanzbericht
News
Neueste
Tweets
vor 3 Wochen 3 Tage
@MorphoSys
Excited to participate in our second virtual conference, #EHA25Virtual, and to share new data on one of our investi… https://t.co/j0mCrLny1j
vor 4 Wochen 1 Tag
@MorphoSys
Our data reflects our commitment to patients suffering from serious diseases. #cancer https://t.co/MwbkMGjWc2
vor 1 Monat 6 Tage
@MorphoSys
#ASCO20 Virtual is a wrap. We look forward to connecting at #EHA25Virtual. https://t.co/hOynUxV2nU
vor 1 Monat 1 Woche
@MorphoSys
Today is #WorldBloodCancerDay. At #MorphoSys, we’re committed to developing therapies to improve the lives of patie… https://t.co/pyB4PdXzPJ
vor 1 Monat 2 Wochen
@MorphoSys
We are proud to announce, together with @Incyte, that @EMA_News has validated the Marketing Authorization Applicati… https://t.co/BbR7EYYGs5
vor 1 Monat 2 Wochen
@MorphoSys
We are excited to be joining medical experts at #ASCO20 Virtual and #EHA25 Virtual this year to present important u… https://t.co/Iz6OQp1ir4
vor 1 Monat 2 Wochen
@MorphoSys
We and our partner Incyte announced long-term follow-up results from one of our investigational medicines for patie… https://t.co/nNXrCjeKtG
vor 2 Monate 3 Tage
@MorphoSys
MorphoSys welcomes Roland Wandeler as new #CCO and Management Board member. “With his track record in #leading and… https://t.co/ul0oTgJvCi
vor 5 Monate 4 Tage
@MorphoSys
Today is #WorldCancerDay2020.
We are fueled by our mission to make exceptional, innovative biopharmaceuticals to i… https://t.co/cxdr0pzGOI
vor 5 Monate 4 Tage
@MorphoSys
20 years ago, #WorldCancerDay was established to acknowledge the impact of cancer on human life and society. Aiming… https://t.co/ezH7lKhrX6
Investorenkontakt
Dr. Julia Neugebauer
Director Corporate Communications & Investor Relations
Telefon +49 89 89927 179
Medienkontakt
Dr. Anca Ammon
Associate Director Corporate Communications & Investor Relations
Telefon +49 89 89927 26738
Dr. Verena Kupas
Associate Director Corporate Communications & Investor Relations
Telefon +49 89 89927 26814